TrialPituitary2019

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing's disease: interim results from a long-term real-world evidence study.

Luca Manetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.